MedTrace Logo

Evaluation of a New Regional Organization to Promote Access to Renal Transplantation

NCT03234075 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2020-01-29

No results posted yet for this study

Summary

Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective treatment. Early and equitable access to transplantation is a public health issue. Access to transplantation is facilitated by early and systematic information and assessment of patients for inclusion in the national waiting list for transplantation prior to the onset of dialysis, and by the development of transplantation from living donors. In France, there are wide disparities in access to national waiting list registration and transplantation. One of the causes of these inequalities in access would be the disparity in referral practices to a transplant medical and surgical team authorized to register the individual on the national waiting list.

The aim of the TRACE study is to evaluate the impact of a new regional organization promoting renal transplantation on access to renal transplantation.

Conditions

  • Renal Failure

Interventions

OTHER

Regional organization for promotion of renal transplantation

Early identification of candidates for renal transplantation * with the help of a care coordinator Inform all patients appropriately about the techniques of renal function supplementation * delivered by expert patients and a care coordinator Assist the nephrologists in patient graft pathway * Multidisciplinary assessment of patients in dedicated web-conferencing meetings bringing together nephrologists and transplant team (" WebRCP of kidney transplant orientation") * Helping to carry out the pre-graft assessments of patients by a care coordinator

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2023-01-01
Completion
2023-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03234075 on ClinicalTrials.gov